Annual Drug Patent Expirations for ALECENSA
Alecensa is a drug marketed by Hoffmann-la Roche and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has one hundred and ten patent family members in thirty-eight countries.
The generic ingredient in ALECENSA is alectinib hydrochloride. One supplier is listed for this compound. Additional details are available on the alectinib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
